Aptevo Therapeutics (APVO)
(Real Time Quote from BATS)
$0.70 USD
+0.02 (2.94%)
Updated Apr 26, 2024 03:42 PM ET
2-Buy of 5 2
C Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -14.10 |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -8.85 |
Next Year | -5.65 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 3.11M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -14.10 | -1.89 | -8.85 | -5.65 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -14.10 | -1.89 | -8.85 | -5.65 |
High Estimate | -14.10 | -1.89 | -8.85 | -5.65 |
Low Estimate | -14.10 | -1.89 | -8.85 | -5.65 |
Year ago EPS | 11.45 | -54.19 | -66.96 | -8.85 |
Year over Year Growth Est. | -223.14% | 96.51% | 86.78% | 36.16% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -14.10 | -1.89 | -8.85 | -5.65 |
7 Days Ago | -15.65 | -13.91 | -57.83 | -55.65 |
30 Days Ago | -15.65 | -13.91 | -57.83 | -55.65 |
60 Days Ago | -15.86 | -14.10 | -58.59 | -56.39 |
90 Days Ago | -15.86 | -14.10 | -58.59 | -56.39 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -14.10 | -1.89 | -8.85 | -5.65 |
Zacks Consensus Estimate | -14.10 | -1.89 | -8.85 | -5.65 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | -22.03 | -54.19 | 11.45 | NA |
Estimate | NA | -31.72 | -49.34 | -52.42 | NA |
Difference | NA | 9.69 | -4.85 | 63.87 | 22.90 |
Surprise | NA | 30.56% | -9.82% | 121.85% | 47.53% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more